bf/NASDAQ:ABOS_icon.jpeg

NASDAQ:ABOS

Acumen Pharmaceuticals, Inc.

  • Stock

USD

Last Close

1.90

06/11 21:09

Market Cap

129.63M

Beta: -

Volume Today

129.63K

Avg: 100.61K

PE Ratio

−3.53

PFCF: −3.92

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '20
Jun '20
Sep '20
Dec '20
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
net income
-2.04M
-
-2.04M
0.49%
-2.49M
22.36%
-755K
69.68%
-27.00M
3,475.76%
-61.36M
127.28%
-3.90M
93.64%
-8.35M
113.97%
-9.13M
9.34%
-10.15M
11.20%
-10.71M
5.51%
-12.87M
20.13%
-11.31M
12.12%
-11.61M
2.68%
-12.96M
11.60%
-16.50M
27.32%
-14.87M
9.84%
-20.54M
38.08%
-29.77M
44.93%
-37.15M
24.82%
depreciation and amortization
3K
-
37K
1,133.33%
39K
5.41%
44K
12.82%
49K
11.36%
52K
6.12%
53K
1.92%
40K
24.53%
39K
2.50%
44K
12.82%
45K
2.27%
-4.64M
10,408.89%
44K
100.95%
deferred income tax
134K
-
415K
-
890K
114.46%
stock based compensation
39K
-
38K
2.56%
39K
2.63%
38K
2.56%
126K
231.58%
127K
0.79%
304K
139.37%
365K
20.07%
618K
69.32%
715K
15.70%
840K
17.48%
888K
5.71%
1.39M
56.53%
1.52M
9.42%
1.60M
5.19%
2.48M
-
2.47M
0.56%
2.34M
5.34%
2.34M
0.21%
change in working capital
190K
-
503K
164.74%
1.17M
132.21%
-1.55M
233.05%
1.28M
182.63%
-973K
175.78%
-4.08M
319.84%
4.07M
199.68%
-41K
101.01%
2.76M
6,834.15%
452K
83.63%
814K
80.09%
24K
97.05%
-1.33M
5,658.33%
-878K
34.18%
6.05M
789.52%
-4.07M
167.18%
3.77M
192.57%
302K
91.98%
8.22M
2,622.19%
accounts receivables
inventory
accounts payables
153K
-
227K
48.37%
851K
274.89%
-923K
208.46%
387K
141.93%
354K
8.53%
-890K
351.41%
706K
179.33%
121K
82.86%
459K
279.34%
416K
9.37%
-444K
206.73%
-878K
97.75%
1.26M
243.74%
-662K
152.46%
17K
102.57%
1.70M
9,900%
1.12M
33.94%
-1.86M
265.63%
3.31M
277.74%
other working capital
37K
-
276K
645.95%
317K
14.86%
-631K
299.05%
897K
242.16%
-1.33M
247.94%
-3.19M
140.77%
3.37M
205.35%
-162K
104.81%
2.30M
1,520.99%
36K
98.44%
1.26M
3,394.44%
902K
28.30%
-2.60M
387.80%
-216K
91.68%
6.04M
2,894.91%
-5.77M
195.53%
2.64M
145.81%
2.16M
18.17%
4.92M
127.34%
other non cash items
-586K
-
23.22M
4,061.95%
57.94M
149.56%
-5K
100.01%
136K
2,820%
216K
58.82%
168K
22.22%
191K
13.69%
-88K
146.07%
-334K
279.55%
-715K
114.07%
-1.60M
123.78%
2.09M
230.63%
-575K
127.51%
-851K
48%
7.17M
942.30%
-669K
109.33%
net cash provided by operating activities
-1.82M
-
-1.49M
17.73%
-1.28M
14.12%
-2.86M
122.68%
-2.37M
17.05%
-4.26M
79.92%
-7.69M
80.30%
-3.64M
52.67%
-8.30M
128.06%
-6.47M
22.06%
-9.18M
41.98%
-11.20M
22.00%
-10.18M
9.18%
-11.67M
14.69%
-12.90M
10.58%
-8.31M
35.58%
-17.86M
114.81%
-16.55M
7.36%
-24.60M
48.66%
-27.21M
10.65%
investments in property plant and equipment
-8K
-
-26K
225%
-9K
65.38%
-36K
300%
-81K
125%
-35K
56.79%
-7K
-
-14K
100%
-11K
21.43%
-5K
54.55%
acquisitions net
-94.09M
-
20.39K
-
3K
-
purchases of investments
-9.98M
-
-9.09M
8.96%
-3.04M
66.57%
-29.39M
-
-52.13M
77.41%
-126.73M
-
-71.78M
43.36%
-45.29M
36.90%
-11.80M
73.94%
-98.54M
735.00%
-15.10M
84.68%
sales maturities of investments
-104.08M
-
4M
103.84%
11.86M
196.50%
56M
372.18%
9M
83.93%
10.20M
13.38%
11.06M
8.43%
34.73M
213.89%
22.98M
33.82%
36.10M
57.07%
49.51M
37.13%
88.41M
78.58%
44.76M
49.37%
other investing activites
-94.09M
-
198.18M
310.61%
-20.39K
-
net cash used for investing activites
-94.10M
-
-10.01M
89.36%
-5.10M
49.07%
8.79M
272.29%
55.92M
536.53%
-20.42M
136.52%
-41.93M
105.32%
11.06M
126.39%
-92.00M
931.53%
-48.81M
46.95%
-9.20M
81.14%
37.70M
509.64%
-10.13M
126.88%
29.66M
392.77%
debt repayment
-29.52M
-
-739K
97.50%
common stock issued
-3K
-
-263K
-
3.79M
1,541.83%
-145K
-
122.76M
84,764.83%
-390K
100.32%
7.88M
2,120%
-128K
101.62%
188K
246.88%
common stock repurchased
-32K
-
-9K
-
dividends paid
other financing activites
44.67M
-
31.68M
-
168.78M
432.85%
13K
99.99%
-14K
-
392K
-
-799K
-
-42K
-
net cash used provided by financing activities
44.67M
-
31.68M
-
168.78M
432.85%
10K
99.99%
-14K
-
-263K
1,778.57%
4.18M
1,690.87%
-145K
-
122.76M
84,764.83%
29.13M
76.27%
7.11M
75.61%
-128K
101.80%
-42K
67.19%
-9K
78.57%
effect of forex changes on cash
6K
-
-16.26M
-
-44.00K
99.73%
net change in cash
-1.82M
-
-1.49M
17.73%
-1.28M
14.12%
41.82M
3,359.39%
-2.37M
105.67%
27.41M
1,256.33%
66.99M
144.44%
-13.64M
120.36%
-13.40M
1.77%
2.30M
117.19%
46.47M
1,917.93%
-27.44M
159.04%
-52.10M
89.88%
-751K
98.56%
17.86M
2,477.90%
-28.03M
256.97%
-19.96M
28.81%
21.02M
205.36%
-34.53M
264.26%
2.44M
107.06%
cash at beginning of period
6.55M
-
4.74M
27.72%
3.24M
31.55%
1.96M
39.57%
43.78M
2,134.66%
41.41M
5.41%
68.81M
66.18%
135.80M
97.35%
122.16M
10.04%
108.76M
10.97%
111.07M
2.12%
157.54M
41.84%
130.10M
17.42%
78.00M
40.05%
77.25M
0.96%
94.92M
22.87%
66.89M
29.53%
46.93M
29.84%
67.95M
44.80%
33.42M
50.82%
cash at end of period
4.74M
-
3.24M
31.55%
1.96M
39.57%
43.78M
2,134.66%
41.41M
5.41%
68.81M
66.18%
135.80M
97.35%
122.16M
10.04%
108.76M
10.97%
111.07M
2.12%
157.54M
41.84%
130.10M
17.42%
78.00M
40.05%
77.25M
0.96%
95.11M
23.12%
66.89M
29.67%
46.93M
29.84%
67.95M
44.80%
33.42M
50.82%
35.86M
7.30%
operating cash flow
-1.82M
-
-1.49M
17.73%
-1.28M
14.12%
-2.86M
122.68%
-2.37M
17.05%
-4.26M
79.92%
-7.69M
80.30%
-3.64M
52.67%
-8.30M
128.06%
-6.47M
22.06%
-9.18M
41.98%
-11.20M
22.00%
-10.18M
9.18%
-11.67M
14.69%
-12.90M
10.58%
-8.31M
35.58%
-17.86M
114.81%
-16.55M
7.36%
-24.60M
48.66%
-27.21M
10.65%
capital expenditure
-8K
-
-26K
225%
-9K
65.38%
-36K
300%
-81K
125%
-35K
56.79%
-7K
-
-14K
100%
-11K
21.43%
-5K
54.55%
free cash flow
-1.82M
-
-1.49M
17.73%
-1.28M
14.12%
-2.86M
122.68%
-2.37M
17.05%
-4.26M
79.92%
-7.70M
80.49%
-3.67M
52.38%
-8.31M
126.68%
-6.50M
21.71%
-9.26M
42.44%
-11.24M
21.31%
-10.18M
9.46%
-11.67M
14.69%
-12.91M
10.64%
-8.33M
35.50%
-17.87M
114.58%
-16.55M
7.39%
-24.60M
48.62%
-27.21M
10.65%

All numbers in USD (except ratios and percentages)